Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Leptin | 1 | ng/mL | 1 | RANTES | 74.0 | 55 | ||||
N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | RANTES | 99.5 | 42 | |
N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | RANTES | 51.0 | 70 | |
N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | RANTES | 94.0 | 48 | |
N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | RANTES | 74.0 | 49 | |
N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | RANTES | 64.5 | 20 | |
RA2159 | 1 | RANTES | 235.0 | 61 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | RANTES | 285.5 | 70 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | RANTES | 106.0 | 53 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | RANTES | 72.0 | 54 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | RANTES | 70.0 | 81 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | RANTES | 65.0 | 78 | ||||
RA2159 | 1 | RANTES | 46.5 | 72 | |||||||
N2586 | 1 | RANTES | 45.0 | 51 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | RANTES | 76.5 | 72 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | RANTES | 102.0 | 51 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | RANTES | 45.0 | 64 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | RANTES | 215.0 | 58 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | RANTES | 42.0 | 62 | ||||
N2586 | 1 | RANTES | 79.5 | 56 | |||||||
RA2159 | Visfatin | 1 | ng/mL | 1 | RANTES | 101.0 | 52 | ||||
RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | RANTES | 67.5 | 80 | |
RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | RANTES | 85.0 | 49 | |
RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | RANTES | 121.0 | 74 | |
RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | RANTES | 81.5 | 42 |